Status:
COMPLETED
Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon
Lead Sponsor:
Centre de Recherche Médicale de Lambaréné
Conditions:
Helminths Infection
Drug Resistance
Eligibility:
All Genders
2-17 years
Phase:
PHASE4
Brief Summary
Soil-transmitted helminths (STHs) infections are common in subtropics and mostly affect the poorest communities, with an impact on human health in many parts of the world. In 2017, World Health organi...
Detailed Description
A Randomized Controlled Clinical Trial (RCT) cohort study, to evaluate the efficacy and safety of three benzimidazole derivates drug (Albendazole, Mebendazole, Albendazole Mebendazole, and Albendazole...
Eligibility Criteria
Inclusion
- Living in Lambaréné and surrounding areas
- Written informed consent or assent
- Microscopy positive for any major Soil-Transmitted helminths
Exclusion
- Microscopy negative for any STH
- Pregnant women
- Do not be available for followed up.
Key Trial Info
Start Date :
November 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT04326868
Start Date
November 11 2019
End Date
January 30 2021
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherches Médicales de Lammbaréné
Lambaréné, Moyen-Ogooué Province, Gabon, 1437